 prostacyclin analog respons tissue-typ plasminogen activ coronari thrombolysi evid pharmacokinet interact inhibit thromboxan TX aspirin enhanc respons coronari thrombolysi experiment evid platelet activ coronari thrombolysi number agonist addit consequ benefit antiplatelet agent spectrum activ recent clinic trial tissu plasminogen activ t-pa prostacyclin analog iloprost benefit mechan respons effect iloprost stabl analog prostacyclin endoperoxid receptor antagonist respons t-pa close chest canin model coronari thrombosi time reperfus consist role platelet activ thrombolysi contrast iloprost time reperfus NS anim reperfus inhibit platelet aggreg separ seri experi steady-st plasma t-pa clearanc ml/min infus iloprost withdraw specif effect infus nitroglycerin dose similar fall blood pressur time iloprost thrombolyt respons t-pa increas clearanc agent